| 000 | 01797 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516154523.0 | ||
| 264 | 0 | _c20140210 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1349-7235 | ||
| 024 | 7 |
_a10.2169/internalmedicine.52.0094 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKomada, Takanori | |
| 245 | 0 | 0 |
_aAcute kidney injury in a patient with nephrotic syndrome due to focal segmental glomerular nephritis induced by a single oral administration of high-dose bisphosphonate (minodronate). _h[electronic resource] |
| 260 |
_bInternal medicine (Tokyo, Japan) _c2013 |
||
| 300 |
_a1383-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xblood |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 |
_aGlomerulosclerosis, Focal Segmental _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xblood |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 700 | 1 | _aMorishita, Yoshiyuki | |
| 700 | 1 | _aKitamura, Masafumi | |
| 700 | 1 | _aIwazu, Kana | |
| 700 | 1 | _aNumata, Akihiko | |
| 700 | 1 | _aKobayashi, Takahisa | |
| 700 | 1 | _aYamamoto, Hisashi | |
| 700 | 1 | _aAkimoto, Tetsu | |
| 700 | 1 | _aSaito, Osamu | |
| 700 | 1 | _aAndo, Yasuhiro | |
| 700 | 1 | _aTakemoto, Fumi | |
| 700 | 1 | _aMuto, Shigeaki | |
| 700 | 1 | _aYumura, Wako | |
| 700 | 1 | _aKusano, Eiji | |
| 773 | 0 |
_tInternal medicine (Tokyo, Japan) _gvol. 52 _gno. 12 _gp. 1383-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2169/internalmedicine.52.0094 _zAvailable from publisher's website |
| 999 |
_c22843604 _d22843604 |
||